Navigation Links
Angel investing should lead to more venture funding, Ward says

Madison - Wisconsin may have received only three of the 35 Midwestern venture capital deals reported during the first quarter of 2006, but one local observer isn\'t alarmed.

A MoneyTree Report released this week said 35 Midwestern companies attracted a total of $185 million during the quarter, compared to three Wisconsin companies with at least $......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 04/26/06


Page: 1 2 3

Related biology technology :

1. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
2. Angel investors commit $12.7B in first half of `06
3. Angel network introduces ePlan
4. Angel fund to focus on women and minority businesses
5. Angel investing should lead to more venture funding, Ward says
6. Midwest fares surprisingly well at Venture Forum in Los Angeles
7. Bone Care bought for $600 million; Wisconsin Angel Network launches
8. Wisconsin Angel Network is part of states focus on entrepreneurship
9. Angel groups in Chicagoland beginning to sprout
10. Angel investor boot camp advises and educates cherubs
11. Angels step up

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Angel investing should lead more venture funding Ward says

(Date:11/29/2009)... This release is available in German . , Th...as in modern physics. The most famous example is t...and neutrons. Now Prof. Bella Lake from Helmholtz-... of scientists report for the first time an experi...omenon observed in a condensed matter system. , ...
(Date:11/27/2009)..., , DURHAM, N.C., Nov. 27 /PRNewswire/..., will initiate water-soluble carbon nanotube-base... The water-soluble carbon nanotubes, which have fu...gation with cancer drugs, was developed in partner...e conjugated carbon nanotubes serves as a drug del...
(Date:11/27/2009)... A mechanised blue dye tes...n to packaging quality assurance one step closer f...contact leak testing machine developed by Sepha...en installed in several local and global pharma-co... address quality assurance and productivity improv...
(Date:11/25/2009)..., , DURHAM, N.C., Nov. 25 /PRNewswire/...led the first energy-efficient, single-treatment w...om carbon nanotubes to Andhra Pradesh, Minister of...her leaders in Hyderabad, India today. Initial tes...IT) Kanpur, confirmed that the majority of the dri...
Breaking Biology Technology:Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2
...England and PHILADELPHIA, Pennsylvania, April 15, ...OSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR...NCEMENT EXCEPT ON THE BASIS OF,INFORMATION TO BE C...D BY,SHIRE LIMITED IN CONNECTION WITH THE PROPOSED... AVAILABLE ON SHIRE,S WEBSITE AND WILL BE AVAILABL...
... April 14 Symmetry Medical Inc.,(NYSE: SMA ), a ...obal,orthopedic device industry and other medical ...07 Annual Report on Form 10-K with the Securities ... previously announced April,14, 2008 target. The f...ubstantially completed. The Company said the focus...
...l 14 /PRNewswire-FirstCall/ - Oncolytics Biotech I...leted patient enrolment in,the dose escalation por...ti-tumour effects of systemic administration of RE...platin in patients with advanced,cancers including... preliminary results from this combination trial a...
Other Biology Technology:Shire to Introduce a New UK Listed Holding Company 2Shire to Introduce a New UK Listed Holding Company 3Shire to Introduce a New UK Listed Holding Company 4Shire to Introduce a New UK Listed Holding Company 5Shire to Introduce a New UK Listed Holding Company 6Shire to Introduce a New UK Listed Holding Company 7Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target 2Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target 3Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial 2Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial 3
(Date:11/26/2009)... survey carried out in eight European countries ha...fectious disease pandemic could have a significant...s writing in the open access journal BMC Infectio...on school days and weekends/holidays, finding that... Hens, from Hasselt and Antwerp University, Belgiu...
(Date:11/26/2009)...RSA (methicillin-resistant Staphylococcus Aureus ...ihilation as low-temperature plasma prototype devi... and unfailing bactericidal cocktails. , Two pro...ent disinfection of healthy skin (e.g. hands and f... can pose a lethal threat; and another to shoot ba...
(Date:11/25/2009)...thens, Ga. Bacteria don,t have easy lives. In add... bugs, they have natural enemies called bacterioph... every two days. , Still, bacteria and another ...overed in extreme environments such as deep-sea vo... because they have a built-in defense system that ...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 1Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 2Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 3Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 1Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 2Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 3EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 1EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 2EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 3
... LA JOLLA, Calif., April 17, 2009 -- Burnham Inst... announce that five of its postdoctoral fellows wi...can Association for Cancer Research (AACR) 100th A...., Ph.D., Burnham President and CEO, Professor and...l on Apoptosis-based Strategies for Cancer Therapy...
... ARLINGTON, VA. The Office of Naval Research (ON...recipients of the U.S. Navy,s 2009 Young Investiga... tapping the brightest young minds in science, tec...of Naval Research RADM Nevin Carr Jr. "With invest...rogram, ONR is encouraging the growth of tomorrow,...
... NEW ORLEANSAlzheimer,s disease (AD) is a tragic ...d mental capacity. One in eight people over the ag... people over 85 are diagnosed with the disease. Co...y affect the elderly. Familial Alzheimer,s disease...as young as 30. , The Study , Alzheimer,s is a...
Other Biology News:ONR announces 2009 Young Investigator Award recipients 2Computational model examines the pathways of Alzheimer's that strikes at the young 2
Rat Anti-p19ARF Monoclonal Antibody, Unconjugated, Clone 5-C3-1 from Upstate
EDTA, tetrasodium salt from GE Healthcare, formerly Amersham Biosciences
Tracker Datamatrix RS-1* from Micronic BV
GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
Biology Products: